Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation

Completed

Phase N/A Results

Eligibility Criteria

Inclusion criteria:
- Pradaxa® prescribers (cardiologists and primary care physicians)
- Patients with atrial fibrillation treated with Pradaxa®
Exclusion criteria:
As defined in Summary of Product Characteristics for patients treated with Pradaxa®